{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:18:28Z","timestamp":1791163108396,"version":"4.1.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010221","name":"Higher Education Commision, Pakistan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010221","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010139","name":"Lahore University of Management Sciences","doi-asserted-by":"publisher","award":["STG-BIO-1009"],"award-info":[{"award-number":["STG-BIO-1009"]}],"id":[{"id":"10.13039\/100010139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010139","name":"Lahore University of Management Sciences","doi-asserted-by":"publisher","award":["FIF-253"],"award-info":[{"award-number":["FIF-253"]}],"id":[{"id":"10.13039\/100010139","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.bmc.2025.118160","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T01:54:28Z","timestamp":1742522068000},"page":"118160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Computational identification and experimental characterization of an aurora kinase inhibitor"],"prefix":"10.1016","volume":"123","author":[{"given":"Muhammad","family":"Muddassar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Furqan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Numan","family":"Yousaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Saad","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saira","family":"Dar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Fozail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahman Shah Zaib","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Shahzad","family":"ul Hussan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7376-8286","authenticated-orcid":false,"given":"Amir","family":"Faisal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2025.118160_b0005","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nrc1502","article-title":"Aurora-kinase inhibitors as anticancer agents","volume":"4","author":"Keen","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bmc.2025.118160_b0010","article-title":"Aurora kinases: structure, functions and their association with cancer","volume":"152","author":"Kollareddy","year":"2008","journal-title":"Biomedical Papers of the Medical Faculty of Palacky University in Olomouc"},{"key":"10.1016\/j.bmc.2025.118160_b0015","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrc1526","article-title":"Aurora-A\u2014a guardian of poles","volume":"5","author":"Marumoto","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bmc.2025.118160_b0020","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/cm.10120","article-title":"Dynamic association of a tumor amplified kinase, Aurora\u2010A, with the centrosome and mitotic spindle","volume":"55","author":"Stenoien","year":"2003","journal-title":"Cell Motil Cytoskelet"},{"key":"10.1016\/j.bmc.2025.118160_b0025","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0962-8924(99)01658-X","article-title":"The Aurora\/Ipl1p kinase family: regulators of chromosome segregation and cytokinesis","volume":"9","author":"Bischoff","year":"1999","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.bmc.2025.118160_b0030","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1083\/jcb.200604032","article-title":"The chromosomal passenger complex: guiding Aurora-B through mitosis","volume":"173","author":"Vader","year":"2006","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bmc.2025.118160_b0035","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/nrm1245","article-title":"The cellular geography of aurora kinases","volume":"4","author":"Carmena","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.bmc.2025.118160_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/1541-7786.MCR-06-0208","article-title":"Roles of Aurora kinases in mitosis and tumorigenesis","volume":"5","author":"Fu","year":"2007","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.bmc.2025.118160_b0045","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.gyobfe.2009.04.002","article-title":"Function of aurora kinase C (AURKC) in human reproduction","volume":"37","author":"Harbuz","year":"2009","journal-title":"Gynecologie, Obstetrique Fertilite"},{"key":"10.1016\/j.bmc.2025.118160_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003318","article-title":"Use of long term molecular dynamics simulation in predicting cancer associated SNPs","volume":"10","author":"Kumar","year":"2014","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.bmc.2025.118160_b0055","doi-asserted-by":"crossref","first-page":"33177","DOI":"10.1074\/jbc.M109.032722","article-title":"A cancer-associated aurora A mutant is mislocalized and misregulated due to loss of interaction with TPX2","volume":"284","author":"Bibby","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2025.118160_b0060","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1038\/s41388-021-01766-w","article-title":"Nuclear localisation of Aurora-A: its regulation and significance for Aurora-A functions in cancer","volume":"40","author":"Naso","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.bmc.2025.118160_b0065","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ceb.2007.11.008","article-title":"Polo and Aurora kinases\u2014lessons derived from chemical biology","volume":"20","author":"Taylor","year":"2008","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.bmc.2025.118160_b0070","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/jjco\/hyv058","article-title":"Prognostic value of Aurora kinase A (AURKA) expression among solid tumor patients: a systematic review and meta-analysis","volume":"45","author":"Zhang","year":"2015","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.bmc.2025.118160_b0075","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1158\/1078-0432.CCR-07-2179","article-title":"Aurora kinases as anticancer drug targets","volume":"14","author":"Gautschi","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmc.2025.118160_b0080","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1080\/15384101.2019.1643658","article-title":"Identification and evaluation of novel drug combinations of Aurora kinase inhibitor CCT137690 for enhanced efficacy in oral cancer cells","volume":"18","author":"Furqan","year":"2019","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bmc.2025.118160_b0085","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1007\/s10637-012-9798-6","article-title":"Aurora kinase inhibitors: progress towards the clinic","volume":"30","author":"Kollareddy","year":"2012","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.bmc.2025.118160_b0090","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1158\/1078-0432.CCR-11-1536","article-title":"Characterization of Alisertib (MLN8237), an investigational small-molecule inhibitor of aurora A kinase using novel in vivo pharmacodynamic assays","volume":"17","author":"Manfredi","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmc.2025.118160_b0095","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s10637-016-0375-2","article-title":"A phase I trial of the aurora kinase inhibitor, ENMD-2076, in patients with relapsed or refractory acute myeloid leukemia or chronic myelomonocytic leukemia","volume":"34","author":"Yee","year":"2016","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.bmc.2025.118160_b0100","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1073\/pnas.0608798104","article-title":"Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase","volume":"104","author":"Manfredi","year":"2007","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmc.2025.118160_b0105","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1158\/1535-7163.MCT-16-0298","article-title":"Barasertib (AZD1152), a small molecule Aurora B inhibitor, inhibits the growth of SCLC cell lines in vitro and in vivo","volume":"15","author":"Helfrich","year":"2016","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bmc.2025.118160_b0110","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.molcel.2005.03.031","article-title":"Mechanism of Aurora B activation by INCENP and inhibition by hesperadin","volume":"18","author":"Sessa","year":"2005","journal-title":"Mol Cell"},{"key":"10.1016\/j.bmc.2025.118160_b0115","doi-asserted-by":"crossref","first-page":"8599","DOI":"10.1073\/pnas.1002471107","article-title":"Flow of energy in the outer retina in darkness and in light","volume":"107","author":"Linton","year":"2010","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2025.118160_b0120","doi-asserted-by":"crossref","first-page":"9846","DOI":"10.1158\/0008-5472.CAN-10-3001","article-title":"Preclinical evaluation of AMG 900, a novel potent and highly selective pan-aurora kinase inhibitor with activity in taxane-resistant tumor cell lines","volume":"70","author":"Payton","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.bmc.2025.118160_b0125","first-page":"1442","article-title":"AT-9283, a small-molecule multi-targeted kinase inhibitor for the potential treatment of cancer","volume":"11","author":"Kimura","year":"2010","journal-title":"Current Opinion Invest Drugs (London, England: 2000)"},{"key":"10.1016\/j.bmc.2025.118160_b0130","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nm1003","article-title":"VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo","volume":"10","author":"Harrington","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.bmc.2025.118160_b0135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.critrevonc.2017.09.006","article-title":"Critical risk-benefit assessment of the novel anti-cancer aurora a kinase inhibitor alisertib (MLN8237): A comprehensive review of the clinical data","volume":"119","author":"Tayyar","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.bmc.2025.118160_b0145","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.ejca.2011.07.008","article-title":"Phase I, open-label, multicentre, dose-escalation, pharmacokinetic and pharmacodynamic trial of the oral aurora kinase inhibitor PF-03814735 in advanced solid tumours","volume":"47","author":"Schoffski","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bmc.2025.118160_b0150","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s10637-013-9950-y","article-title":"A phase I schedule dependency study of the aurora kinase inhibitor MSC1992371A in combination with gemcitabine in patients with solid tumors","volume":"32","author":"Raymond","year":"2014","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.bmc.2025.118160_b0155","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.16_suppl.8572","article-title":"A phase I\/Ib study of the aurora kinase A inhibitor alisertib in combination with osimertinib in advanced osimertinib-resistant EGFR-mutated lung cancer","author":"Chakrabarti","year":"2024","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.bmc.2025.118160_b0160","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1080\/07391102.2020.1772109","article-title":"Targeting the protein-protein interface pocket of Aurora-A-TPX2 complex: rational drug design and validation","volume":"39","author":"Bhardwaj","year":"2021","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.bmc.2025.118160_b0165","doi-asserted-by":"crossref","first-page":"11104","DOI":"10.1002\/jcb.28387","article-title":"Gain of native conformation of Aurora A S155R mutant by small molecules","volume":"120","author":"Tanwar","year":"2019","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.bmc.2025.118160_b0170","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fonc.2015.00278","article-title":"Aurora kinase inhibitors: current status and outlook","volume":"5","author":"Bavetsias","year":"2015","journal-title":"Front Oncol"},{"key":"10.1016\/j.bmc.2025.118160_b0175","doi-asserted-by":"crossref","first-page":"23937","DOI":"10.18632\/oncotarget.14893","article-title":"Aurora kinases: novel therapy targets in cancers","volume":"8","author":"Tang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bmc.2025.118160_b0180","series-title":"Seminars in Oncology","article-title":"Aurora kinase inhibitors in oncology clinical trials: current state of the progress","author":"Falchook","year":"2015"},{"key":"10.1016\/j.bmc.2025.118160_b0185","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00280-010-1377-y","article-title":"Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors","volume":"67","author":"Dees","year":"2011","journal-title":"Cancer Chemotherapy Pharmacol"},{"key":"10.1016\/j.bmc.2025.118160_b0190","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/cbdd.13850","article-title":"Design strategies, SAR, and mechanistic insight of Aurora kinase inhibitors in cancer","volume":"98","author":"Sankhe","year":"2021","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.bmc.2025.118160_b0195","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s12276-021-00635-6","article-title":"Aurora kinase A, a synthetic lethal target for precision cancer medicine","volume":"53","author":"Mou","year":"2021","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.bmc.2025.118160_b0200","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41591-018-0264-7","article-title":"Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer","volume":"25","author":"Shah","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.bmc.2025.118160_b0205","first-page":"1","article-title":"Role of aurora kinase B in regulating resistance to paclitaxel in breast cancer cells","author":"Liu","year":"2022","journal-title":"Hum Cell"},{"key":"10.1016\/j.bmc.2025.118160_b0210","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1021\/cb100053q","article-title":"Drug-resistant aurora A mutants for cellular target validation of the small molecule kinase inhibitors MLN8054 and MLN8237","volume":"5","author":"Sloane","year":"2010","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.bmc.2025.118160_b0215","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1021\/jm800984v","article-title":"Fragment-based discovery of the pyrazol-4-yl urea (AT9283), a multitargeted kinase inhibitor with potent aurora kinase activity","volume":"52","author":"Howard","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118160_b0220","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.molstruc.2010.08.050","article-title":"Identification of critical chemical features for Aurora kinase-B inhibitors using Hip-Hop, virtual screening and molecular docking","volume":"985","author":"Sakkiah","year":"2011","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmc.2025.118160_b0225","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1021\/ci8004226","article-title":"How to optimize shape-based virtual screening: choosing the right query and including chemical information","volume":"49","author":"Kirchmair","year":"2009","journal-title":"J Chem Inform Model"},{"key":"10.1016\/j.bmc.2025.118160_b0230","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10822-014-9807-2","article-title":"Identification of ligand efficient, fragment-like hits from an HTS library: structure-based virtual screening and docking investigations of 2H-and 3H-pyrazolo tautomers for Aurora kinase A selectivity","volume":"29","author":"Sarvagalla","year":"2015","journal-title":"J Comput Aided Mol Des"},{"key":"10.1016\/j.bmc.2025.118160_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-022-01852-3","article-title":"Targeting aurora kinase a (AURKA) in cancer: molecular docking and dynamic simulations of potential AURKA inhibitors","volume":"39","author":"Almilaibary","year":"2022","journal-title":"Med Oncol"},{"key":"10.1016\/j.bmc.2025.118160_b0240","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.18632\/oncotarget.26714","article-title":"Aurora A inhibition limits centrosome clustering and promotes mitotic catastrophe in cells with supernumerary centrosomes","volume":"10","author":"Navarro-Serer","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.bmc.2025.118160_b0245","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1128\/MCB.02364-06","article-title":"MLN8054, a small-molecule inhibitor of Aurora A, causes spindle pole and chromosome congression defects leading to aneuploidy","volume":"27","author":"Hoar","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bmc.2025.118160_b0250","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1091\/mbc.e02-11-0769","article-title":"Exploring the functional interactions between Aurora B, INCENP, and survivin in mitosis","volume":"14","author":"Honda","year":"2003","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.bmc.2025.118160_b0255","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1158\/1535-7163.MCT-11-0333","article-title":"The aurora kinase inhibitor CCT137690 downregulates MYCN and sensitizes MYCN-amplified neuroblastoma in vivo","volume":"10","author":"Faisal","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bmc.2025.118160_b0260","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/CMR.0b013e32835df5e4","article-title":"The pan-Aurora kinase inhibitor, PHA-739358, induces apoptosis and inhibits migration in melanoma cell lines","volume":"23","author":"Xie","year":"2013","journal-title":"Melanoma Res"},{"key":"10.1016\/j.bmc.2025.118160_b0265","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1158\/1078-0432.CCR-06-2979","article-title":"AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis","volume":"13","author":"Wilkinson","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmc.2025.118160_b0270","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1083\/jcb.200208092","article-title":"The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore\u2013microtubule attachment and in maintaining the spindle assembly checkpoint","volume":"161","author":"Hauf","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bmc.2025.118160_b0275","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3324\/haematol.12148","article-title":"Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts","volume":"93","author":"Walsby","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.bmc.2025.118160_b0280","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/sj.cr.7290152","article-title":"Function and regulation of Aurora\/Ipl1p kinase family in cell division","volume":"13","author":"Ke","year":"2003","journal-title":"Cell Res"},{"key":"10.1016\/j.bmc.2025.118160_b0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13008-018-0040-6","article-title":"The functional diversity of Aurora kinases: a comprehensive review","volume":"13","author":"Willems","year":"2018","journal-title":"Cell Div"},{"key":"10.1016\/j.bmc.2025.118160_b0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12248-019-0399-6","article-title":"Structural characterization of the aurora kinase B \u201cDFG-flip\u201d using metadynamics","volume":"22","author":"Lakkaniga","year":"2020","journal-title":"AAPS J"},{"key":"10.1016\/j.bmc.2025.118160_b0295","doi-asserted-by":"crossref","first-page":"784","DOI":"10.4161\/cc.4.6.1693","article-title":"The Aurora A and Aurora B protein kinases: a single amino acid difference controls intrinsic activity and activation by TPX2","volume":"4","author":"Eyers","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bmc.2025.118160_b0300","doi-asserted-by":"crossref","first-page":"18707","DOI":"10.1038\/s41598-021-97368-3","article-title":"Exploration of the structural requirements of Aurora Kinase B inhibitors by a combined QSAR, modelling and molecular simulation approach","volume":"11","author":"Ashraf","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2025.118160_b0305","doi-asserted-by":"crossref","first-page":"9122","DOI":"10.1021\/jm401115g","article-title":"Aurora isoform selectivity: design and synthesis of imidazo [4, 5-b] pyridine derivatives as highly selective inhibitors of Aurora-A kinase in cells","volume":"56","author":"Bavetsias","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118160_b0310","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1021\/jm9000314","article-title":"A class of 2, 4-bisanilinopyrimidine Aurora A inhibitors with unusually high selectivity against Aurora B","volume":"52","author":"Aliagas-Martin","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118160_b0315","doi-asserted-by":"crossref","first-page":"5988","DOI":"10.1016\/j.bmcl.2010.08.091","article-title":"Structure-based design of imidazo [1, 2-a] pyrazine derivatives as selective inhibitors of Aurora-A kinase in cells","volume":"20","author":"Bouloc","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2025.118160_b0320","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1021\/jm801270e","article-title":"Structure-based drug design of novel Aurora kinase A inhibitors: structural basis for potency and specificity","volume":"52","author":"Coumar","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118160_b0325","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.4161\/cc.8.19.9729","article-title":"The aurora B kinase inhibitor AZD1152 sensitizes cancer cells to fractionated irradiation and induces mitotic catastrophe","volume":"8","author":"Tao","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bmc.2025.118160_b0330","unstructured":"1 vROCS."},{"key":"10.1016\/j.bmc.2025.118160_b0335","doi-asserted-by":"crossref","first-page":"16061","DOI":"10.1039\/D0RA02363A","article-title":"Identification of novel bacterial urease inhibitors through molecular shape and structure based virtual screening approaches","volume":"10","author":"Imran","year":"2020","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmc.2025.118160_b0340","unstructured":"Software OS. ROCS\u2014Rapid Overlay of Chemical Structures. 3.1. 0; 2010."},{"key":"10.1016\/j.bmc.2025.118160_b0345","unstructured":"Software OS. OpenEye, OMEGA (Version 2.3. 2); 2006."},{"key":"10.1016\/j.bmc.2025.118160_b0350","unstructured":"Schr\u00f6dinger L. Schr\u00f6dinger, LLC; New York, NY: 2017. Schr\u00f6dinger Suite 2017;2:2017\u20131."},{"key":"10.1016\/j.bmc.2025.118160_b0355","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1021\/ct300203w","article-title":"Improving the prediction of absolute solvation free energies using the next generation OPLS force field","volume":"8","author":"Shivakumar","year":"2012","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.bmc.2025.118160_b0360","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/978-1-4939-6798-8_14","article-title":"Investigating protein\u2013peptide interactions using the Schr\u00f6dinger computational suite","author":"Bhachoo","year":"2017","journal-title":"Model Peptide-Protein Interact"},{"key":"10.1016\/j.bmc.2025.118160_b0365","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J Mol Graph"},{"key":"10.1016\/j.bmc.2025.118160_b0370","doi-asserted-by":"crossref","DOI":"10.1063\/5.0014475","article-title":"Scalable molecular dynamics on CPU and GPU architectures with NAMD","volume":"153","author":"Phillips","year":"2020","journal-title":"J Chem Phys"},{"key":"10.1016\/j.bmc.2025.118160_b0375","unstructured":"Case DA et al. Amber 2021: Reference Manual; 2021."},{"key":"10.1016\/j.bmc.2025.118160_b0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.dib.2021.107401","article-title":"Data for molecular dynamics simulations of Escherichia coli cytochrome bd oxidase with the Amber force field","volume":"38","author":"Ahn","year":"2021","journal-title":"Data Brief"},{"key":"10.1016\/j.bmc.2025.118160_b0385","doi-asserted-by":"crossref","first-page":"12127","DOI":"10.1039\/D1CP01385H","article-title":"Extensive evaluation of environment-specific force field for ordered and disordered proteins","volume":"23","author":"Cui","year":"2021","journal-title":"PCCP"},{"key":"10.1016\/j.bmc.2025.118160_b0390","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1021\/acs.jcim.1c00491","article-title":"Topology automated force-field interactions (TAFFI): A framework for developing transferable force fields","volume":"61","author":"Seo","year":"2021","journal-title":"J Chem Inform Model"},{"key":"10.1016\/j.bmc.2025.118160_b0395","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1021\/acs.jctc.0c01320","article-title":"Parametrization of trivalent and tetravalent metal ions for the OPC3, OPC, TIP3P-FB, and TIP4P-FB water models","volume":"17","author":"Li","year":"2021","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.bmc.2025.118160_b0400","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jcc.26466","article-title":"A method to apply bond\u2010angle constraints in molecular dynamics simulations","volume":"42","author":"Pechlaner","year":"2021","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2025.118160_b0405","doi-asserted-by":"crossref","first-page":"B937","DOI":"10.1137\/20M1371385","article-title":"A random batch Ewald method for particle systems with Coulomb interactions","volume":"43","author":"Jin","year":"2021","journal-title":"SIAM J Sci Comput"},{"key":"10.1016\/j.bmc.2025.118160_b0410","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3390\/biom11060856","article-title":"Molecular dynamics simulations of human FOXO3 reveal intrinsically disordered regions spread spatially by intramolecular electrostatic repulsion","volume":"11","author":"Weinzierl","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.bmc.2025.118160_b0415","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/pro.3923","article-title":"The Bio3D packages for structural bioinformatics","volume":"30","author":"Grant","year":"2021","journal-title":"Protein Sci"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625001014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625001014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T04:28:07Z","timestamp":1746764887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089625001014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":82,"alternative-id":["S0968089625001014"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118160","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Computational identification and experimental characterization of an aurora kinase inhibitor","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118160","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118160"}}